For therapeutic and prognostic purposes, breast cancer (BC) is often classified on the basis of oestrogen receptor (ER), progesterone receptor (PR) and human epidermal growth factor receptor-2 (HER2) expression. This evidence concerns the gene ERBB2 and breast cancer.